angiotensin ii has been researched along with benazeprilat in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (76.92) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hjemdahl, P; Johansson, MC; Kahan, T; Nussberger, J; Schwieler, JH | 1 |
| Hjemdahl, P; Kahan, T; Nussberger, J; Schwieler, JH | 2 |
| Prescott, MF; Reidy, MA; Webb, RL | 1 |
| Baum, HP; Bunkenburg, B; Cumin, F; Schnell, C; Wood, JM | 1 |
| Favilla, S; Mattei, P; Salvetti, A; Taddei, S; Virdis, A | 1 |
| Cumin, F; Kelly, M; Samani, NJ; Wood, JM | 1 |
| Lüscher, TF; Tschudi, MR | 1 |
| de Gasparo, M; Iannini, JP; Melton, DM; Mukherjee, R; Spinale, FG | 1 |
| Duranti, P; Favilla, S; Ghiadoni, L; Marraccini, P; Marzilli, M; Orsini, E; Salvetti, A; Taddei, S; Virdis, A | 1 |
| Mancia, G; Morganti, A; Perondi, R; Pomidossi, G; Saino, A; Turolo, L | 1 |
| Baker, KM; Kumar, R; Singh, VP | 1 |
| Baker, KM; Chandel, N; Kumar, R; Seqqat, R; Thomas, CM; Yong, QC | 1 |
1 trial(s) available for angiotensin ii and benazeprilat
| Article | Year |
|---|---|
Adenosine causes the release of active renin and angiotensin II in the coronary circulation of patients with essential hypertension.
Topics: Acetylcholine; Adenosine; Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Cardiac Catheterization; Coronary Circulation; Dose-Response Relationship, Drug; Female; Forearm; Hemodynamics; Humans; Hypertension; Infusions, Intra-Arterial; Laser-Doppler Flowmetry; Male; Middle Aged; Nitroprusside; Renin; Renin-Angiotensin System | 1999 |
12 other study(ies) available for angiotensin ii and benazeprilat
| Article | Year |
|---|---|
Influence of angiotensin II, alpha- and beta-adrenoceptors on peripheral noradrenergic neurotransmission in canine gracilis muscle in vivo.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Blood Pressure; Dogs; Electric Stimulation; Epinephrine; Female; Hormones; Muscles; Norepinephrine; Peripheral Nerves; Propranolol; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Synaptic Transmission | 1992 |
Nerve stimulation augments angiotensin II overflow from canine gracilis muscle in vivo.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Dogs; Electric Stimulation; Female; Muscles; Receptors, Adrenergic, alpha; Renin-Angiotensin System; Sympathetic Nervous System | 1991 |
Angiotensin-converting enzyme inhibitor versus angiotensin II, AT1 receptor antagonist. Effects on smooth muscle cell migration and proliferation after balloon catheter injury.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Biphenyl Compounds; Blood Pressure; Catheterization; Cell Division; Cell Movement; Imidazoles; Losartan; Male; Muscle, Smooth, Vascular; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Tetrazoles | 1991 |
Prolonged angiotensin II antagonism in spontaneously hypertensive rats. Hemodynamic and biochemical consequences.
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Benzazepines; Biphenyl Compounds; Blood Pressure; Body Weight; Dose-Response Relationship, Drug; Hemodynamics; Imidazoles; Losartan; Male; Myocardium; Nephrectomy; Organ Size; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrazoles; Time Factors | 1991 |
Angiotensin II and sympathetic activity in sodium-restricted essential hypertension.
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Blood Pressure; Diet, Sodium-Restricted; Female; Forearm; Humans; Hypertension; Isoproterenol; Male; Middle Aged; Norepinephrine; Plethysmography; Propranolol; Saralasin; Sympathetic Nervous System; Vasoconstriction | 1995 |
Expression of components of the RAS during prolonged blockade at different levels in primates.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Antibodies, Monoclonal; Benzazepines; Blood Pressure; Callithrix; Female; Kidney; Liver; Male; Oligopeptides; Renin; Renin-Angiotensin System; RNA, Messenger; Tetrazoles; Time Factors; Valine; Valsartan | 1994 |
Characterization of contractile endothelin and angiotensin receptors in human resistance arteries: evidence for two endothelin and one angiotensin receptor.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Azepines; Benzazepines; Bosentan; Endothelin Receptor Antagonists; Endothelins; Humans; In Vitro Techniques; Indoles; Mammary Arteries; Muscle Contraction; Plasmids; Receptors, Angiotensin; Receptors, Endothelin; Sulfonamides; Tetrazoles; Valine; Valsartan; Vasoconstrictor Agents; Viper Venoms | 1994 |
Converting enzyme inhibition modulates sympathetic neurotransmission in vivo via multiple mechanisms.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Biphenyl Compounds; Blood Pressure; Bradykinin; Diclofenac; Dogs; Epinephrine; Female; Imidazoles; Losartan; Muscle Denervation; Muscles; Norepinephrine; Phenoxybenzamine; Sympathetic Nervous System; Synaptic Transmission; Tetrazoles | 1993 |
Angiotensin AT1 receptor inhibition, angiotensin-converting enzyme inhibition, and combination therapy with developing heart failure: cellular mechanisms of action.
Topics: Action Potentials; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Cardiac Pacing, Artificial; Disease Models, Animal; Drug Therapy, Combination; Evaluation Studies as Topic; Heart Failure; Myocardium; Random Allocation; Swine; Ventricular Function, Left | 1998 |
Modulation of sympathetic coronary vasoconstriction by cardiac renin-angiotensin system in human coronary heart disease.
Topics: Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Arteries; Benzazepines; Blood Pressure; Cold Temperature; Coronary Artery Disease; Coronary Vessels; Diving; Hemodynamics; Humans; Male; Middle Aged; Myocardium; Oxygen Consumption; Renin-Angiotensin System; Sodium Chloride; Sympathetic Nervous System; Vasoconstriction | 2000 |
Activation of the intracellular renin-angiotensin system in cardiac fibroblasts by high glucose: role in extracellular matrix production.
Topics: Adrenergic beta-Agonists; Amides; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Newborn; Benzazepines; Benzimidazoles; Biphenyl Compounds; Blotting, Western; Cells, Cultured; Collagen Type I; Dose-Response Relationship, Drug; Extracellular Matrix; Fibroblasts; Fumarates; Glucose; Heart Ventricles; Isoproterenol; Microscopy, Confocal; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Renin; Renin-Angiotensin System; Tetrazoles; Time Factors; Transforming Growth Factor beta; Up-Regulation | 2008 |
Angiotensin type 1a receptor-deficient mice develop diabetes-induced cardiac dysfunction, which is prevented by renin-angiotensin system inhibitors.
Topics: Amides; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Disease Models, Animal; Down-Regulation; Fumarates; Kallikreins; Kininogens; Kinins; Mice; Mice, Knockout; Myocytes, Cardiac; Receptor, Angiotensin, Type 1; Renin; Renin-Angiotensin System; Tetrazoles; Ultrasonography; Valine; Valsartan | 2013 |